|
|
|
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
0:00
0:00
Related Podcasts
28 August 2026
Phil Kerpen, Founder and President of American Commitment, discusses the Inflation Reduction Act’s drug price controls, how they hurt access and innovation, and why they must be repealed and replaced with pro-growth policies and strong intellectual property protections to encourage investment in new life-saving medicines.
03 December 2021
Phil Kerpen, Founder and President of American Commitment, discusses how drug price controls would hurt seniors as they would reduce access to and undermine research and development in life-saving biopharmaceuticals, and why the Build Back Better Act under consideration in Congress is riddled with other disastrous provisions.
19 March 2020
Phil Kerpen, President of American Commitment, discusses how government price controls harm consumers, why price controls on consumer lending and prescription drugs must be rejected, and what to expect if the U.S. Postal Service becomes a lending station.
14 February 2020
Timothy Lee, Senior Vice President of Legal and Public Affairs at CFIF, discusses the DOJ's civil antitrust lawsuit seeking to block Sabre Corporation's acquisition of Farelogix, Inc., and why imported price controls for drugs is a prescription for failure.
03 May 2019
Phil Kerpen, President of American Commitment, discusses prescription drug prices, the fundamental problems with importing foreign price controls, and the steps Congress can take to improve the system.
11 January 2019
Pat Rosenstiel, Founder and Chairman of the Trade Alliance to Promote Prosperity, discusses HHS's proposal to create an "International Pricing Index" payment model for prescription drugs administered under Medicare Part B, why this proposal is bad for Americans and how it will hurt research and development of new drugs.
